TESIVEE Trademark

Trademark Overview


On Friday, March 31, 2006, a trademark application was filed for TESIVEE with the United States Patent and Trademark Office. The USPTO has given the TESIVEE trademark a serial number of 78851273. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 21, 2011. This trademark is owned by Biovail Laboratories International SRL. The TESIVEE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and al...
tesivee

General Information


Serial Number78851273
Word MarkTESIVEE
Filing DateFriday, March 31, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 21, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 6, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiovail Laboratories International SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Party NameBiovail Laboratories International SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSt. Michael
BB

Trademark Events


Event DateEvent Description
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 23, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, March 21, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 21, 2011ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 13, 2010ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 24, 2010EXTENSION 5 GRANTED
Monday, August 16, 2010EXTENSION 5 FILED
Monday, August 16, 2010TEAS EXTENSION RECEIVED
Thursday, February 11, 2010EXTENSION 4 GRANTED
Thursday, February 4, 2010EXTENSION 4 FILED
Thursday, February 4, 2010TEAS EXTENSION RECEIVED
Thursday, August 13, 2009EXTENSION 3 GRANTED
Sunday, July 12, 2009EXTENSION 3 FILED
Wednesday, August 12, 2009TEAS EXTENSION RECEIVED
Wednesday, June 17, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 3, 2009EXTENSION 2 GRANTED
Friday, February 13, 2009EXTENSION 2 FILED
Tuesday, March 3, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 13, 2009TEAS EXTENSION RECEIVED
Thursday, January 22, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 22, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 12, 2008EXTENSION 1 GRANTED
Tuesday, August 12, 2008EXTENSION 1 FILED
Tuesday, August 12, 2008TEAS EXTENSION RECEIVED
Tuesday, February 19, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 7, 2007CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, November 30, 2007FAX RECEIVED
Tuesday, November 27, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2007NOTICE OF PUBLICATION
Friday, October 19, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 19, 2007ASSIGNED TO LIE
Saturday, September 29, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 18, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 13, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 11, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 11, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 11, 2007TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, March 14, 2007FINAL REFUSAL E-MAILED
Wednesday, March 14, 2007FINAL REFUSAL WRITTEN
Tuesday, March 13, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 13, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 13, 2006NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2006NON-FINAL ACTION WRITTEN
Wednesday, September 13, 2006ASSIGNED TO EXAMINER
Thursday, April 6, 2006NEW APPLICATION ENTERED IN TRAM